Interstitial intensity modulated photodynamic therapy phase II
Ended Project Grant Awarded Last action
- Award ID
- R44CA213654
- Recipient
-
Simphotek, Inc. UEI JQ58W3Y1VT11
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,968,105
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- New Jersey, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $2,500 | |
| Amendment | $980,701 | |
| Original award | $984,904 |
Quick answers
Who received award R44CA213654?
R44CA213654 was awarded to Simphotek, Inc. by National Cancer Institute (National Institutes of Health) on June 1, 2017.
How much is award R44CA213654 worth?
$1,968,105 has been obligated on R44CA213654.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award